Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Tryp Therapeutics Inc
(OP:
TRYPF
)
N/A
UNCHANGED
Last Price
Updated: 3:17 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tryp Therapeutics Inc
< Previous
1
2
3
4
Next >
PsychedelicNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Submission of IND Application for Eating Disorders Clinical Trial
September 22, 2021
Via
Investor Brand Network
Exposures
Product Safety
Senate Bill Decriminalizing Psychedelics Could Help Reverse Some “War on Drugs” Impacts
September 22, 2021
Via
FinancialNewsMedia
CORRECTION FROM SOURCE: Tryp Therapeutics to Present at H.C. Wainwright Global Investment Conference
September 01, 2021
A correction from Tryp Therapeutics Inc. is being issued for the news release disseminated earlier today. The correction relates to...
Via
Newsfile
Tryp Therapeutics to Present at H.C. Wainwright Annual Global Investment Conference
September 01, 2021
San Diego, California--(Newsfile Corp. - September 1, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused...
Via
Newsfile
Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida
August 24, 2021
San Diego, California--(Newsfile Corp. - August 24, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a...
Via
Newsfile
Tryp Therapeutics Appoints Dennis Langer, M.D., J.D. as Senior Advisor
August 18, 2021
San Diego, California--(Newsfile Corp. - August 18, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a...
Via
Newsfile
Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations
August 10, 2021
San Diego, California--(Newsfile Corp. - August 10, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a...
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Tryp Therapeutics to Present at Canaccord Genuity Annual Growth Conference
August 03, 2021
San Diego, California--(Newsfile Corp. - August 3, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused...
Via
Newsfile
Tryp Therapeutics Announces Q3 2021 Financial Results
July 28, 2021
San Diego, California--(Newsfile Corp. - July 28, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a...
Via
Newsfile
Tryp Therapeutics Appoints Robin Carhart-Harris, Ph.D. as SAB Chairman and Adds Daniel Clauw, M.D. as Scientific Advisor
July 26, 2021
San Diego, California--(Newsfile Corp. - July 26, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused...
Via
Newsfile
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
July 21, 2021
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan
July 21, 2021
San Diego, California--(Newsfile Corp. - July 21, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused...
Via
Newsfile
Exposures
Product Safety
Tryp Therapeutics to Host Q3 Investor Day on July 29, 2021
July 15, 2021
San Diego, California--(Newsfile Corp. - July 15, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp"), a pharmaceutical company focused...
Via
Newsfile
Tryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary Formulations
July 07, 2021
San Diego, California--(Newsfile Corp. - July 7, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB:TRYPF) ("Tryp"), a pharmaceutical company focused...
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Tryp Therapeutics to Present at the Psych Investor Summit
June 24, 2021
San Diego, California--(Newsfile Corp. - June 24, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical...
Via
Newsfile
Tryp Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
June 08, 2021
San Diego, California--(Newsfile Corp. - June 8, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical...
Via
Newsfile
Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference
June 01, 2021
San Diego, California--(Newsfile Corp. - June 1, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical...
Via
Newsfile
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
May 25, 2021
San Diego, California--(Newsfile Corp. - May 25, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical...
Via
Newsfile
Psychedelics Move to The Forefront of Innovative Research as the FDA Approves Large-Scale Testing
May 13, 2021
Via
FinancialNewsMedia
Exposures
Product Safety
Tryp Therapeutics Partners with Clinlogix for Clinical Trial Support
May 10, 2021
San Diego, California--(Newsfile Corp. - May 10, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical...
Via
Newsfile
Exposures
Product Safety
Tryp Therapeutics Partners with Fluence for Psychotherapy Design
May 03, 2021
San Diego, California--(Newsfile Corp. - May 3, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp") a...
Via
Newsfile
Exposures
Product Safety
Tryp Therapeutics Announces Q2 2021 Financial Results
April 29, 2021
San Diego, California--(Newsfile Corp. - April 29, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("Tryp" or the "Company"), today announced...
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
A Growing Market For Rare Disease Treatments Opens Up New Opportunities
April 28, 2021
Via
FinancialNewsMedia
Tryp Therapeutics Reports on Key Milestones for 2021
April 20, 2021
San Diego, California--(Newsfile Corp. - April 20, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"),...
Via
Newsfile
Topics
Initial Public Offering
Intellectual Property
Exposures
Intellectual Property
Securities Market
Tryp Therapeutics to Host Investor Day on April 22
April 15, 2021
San Diego, California--(Newsfile Corp. - April 15, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"),...
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.